Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease
Can Transcranial Direct Current Stimulation (tDCS)Modulate Protective Stepping and Gait Performance of People With Parkinson's Disease
Sponsor: University of Maryland, Baltimore
Listed as NCT01100762, this NA trial focuses on Parkinson's Disease and remains completed. Sponsored by University of Maryland, Baltimore, it has been updated 14 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Nov 2019 — Nov 2020 [monthly]
Completed NA
Phase: PHASE1_PHASE2 → NA
-
Sep 2019 — Nov 2019 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
-
Aug 2017 — May 2018 [monthly]
Completed PHASE1_PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1_PHASE2
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .